Suppr超能文献

角膜血管生成特权及其失败。

Corneal angiogenic privilege and its failure.

机构信息

Ophthalmology Operative Complex Unit, University Campus Bio-Medico, Rome, Italy.

Ophthalmology Operative Complex Unit, University Campus Bio-Medico, Rome, Italy.

出版信息

Exp Eye Res. 2021 Mar;204:108457. doi: 10.1016/j.exer.2021.108457. Epub 2021 Jan 22.

Abstract

The cornea actively maintains its own avascular status to preserve its ultimate optical function. This corneal avascular state is also defined as "corneal angiogenic privilege", which results from a critical and sensitive balance between anti-angiogenic and pro-angiogenic mechanisms. In our review, we aim to explore the complex equilibrium among multiple mediators which prevents neovascularization in the resting cornea, as well as to unveil the evolutive process which leads to corneal angiogenesis in response to different injuries.

摘要

角膜通过主动维持自身无血管状态来保持其最终光学功能。这种角膜无血管状态也被定义为“角膜血管生成特权”,这是由于抗血管生成和促血管生成机制之间的关键和敏感平衡所致。在我们的综述中,我们旨在探讨阻止静止角膜新生血管形成的多种介质之间的复杂平衡,以及揭示导致角膜对不同损伤发生血管生成的演变过程。

相似文献

1
Corneal angiogenic privilege and its failure.角膜血管生成特权及其失败。
Exp Eye Res. 2021 Mar;204:108457. doi: 10.1016/j.exer.2021.108457. Epub 2021 Jan 22.
2
Inflammatory corneal neovascularization: etiopathogenesis.炎症性角膜新生血管形成:病因发病机制。
Semin Ophthalmol. 2011 Jul-Sep;26(4-5):235-45. doi: 10.3109/08820538.2011.588652.
6
Horizons in therapy for corneal angiogenesis.角膜血管生成治疗的新视野。
Ophthalmology. 2011 Mar;118(3):591-9. doi: 10.1016/j.ophtha.2011.01.041.
7
Lymphangiogenesis new mechanisms.淋巴管生成的新机制。
Ann N Y Acad Sci. 2002 Dec;979:111-9. doi: 10.1111/j.1749-6632.2002.tb04872.x.
8
Limbal stem cell deficiency and corneal neovascularization.角膜缘干细胞缺乏与角膜新生血管形成。
Semin Ophthalmol. 2009 May-Jun;24(3):139-48. doi: 10.1080/08820530902801478.

引用本文的文献

6
Emerging immunologic approaches as cancer anti-angiogenic therapies.新兴的免疫疗法作为癌症抗血管生成治疗手段。
Clin Transl Oncol. 2025 Apr;27(4):1406-1425. doi: 10.1007/s12094-024-03667-2. Epub 2024 Sep 18.
8
Subconjunctival aflibercept inhibits corneal angiogenesis and VEGFR-3CD11b cells.玻璃体内注射阿柏西普抑制角膜血管生成和 VEGFR-3CD11b 细胞。
Graefes Arch Clin Exp Ophthalmol. 2024 Dec;262(12):3881-3888. doi: 10.1007/s00417-024-06560-4. Epub 2024 Jul 9.
9
Role of macrophage in ocular neovascularization.巨噬细胞在眼部新生血管形成中的作用。
Heliyon. 2024 May 7;10(10):e30840. doi: 10.1016/j.heliyon.2024.e30840. eCollection 2024 May 30.

本文引用的文献

1
Regulatory T Cells in Angiogenesis.调节性 T 细胞与血管生成。
J Immunol. 2020 Nov 15;205(10):2557-2565. doi: 10.4049/jimmunol.2000574.
8
Thrombospondin-1 in ocular surface health and disease.血栓反应蛋白-1 与眼表面健康和疾病。
Ocul Surf. 2019 Jul;17(3):374-383. doi: 10.1016/j.jtos.2019.06.001. Epub 2019 Jun 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验